26/04/2020

Le SARS-CoV-2 se réplique incroyablement vite #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance

D’après une nouvelle étude, non seulement le nouveau coronavirus infecte beaucoup plus vite les cellules que le SRAS de 2003, mais il produit également 3,2 fois plus de particules virales en 48 heures..

Source: www.pourquoidocteur.fr

26/04/2020

Maccabi to deploy AI that identifies patients at risk of developing COVID-19 complications #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance

An HMO developing a platform for the discovery of clinical insights from medial information, Israel’s Maccabi Healthcare Services, plans to deploy an AI system that can identify people at risk of developing COVID-19 complications. The work is being done in partnership with the Kahn-Sagol-Maccabi Research and Innovation Institute and Medial EarlySign and looks at factors like preexisting conditions, the three organizations announced today. The AI could enable the HMO to fast-track patients for testing at a time when COVID-19 test kits are tough to come by. As of early this month — citing a growing shortage of reagents — the Israel Health Ministry said it wouldn’t test people for COVID-19 symptoms unless they had recently traveled.

According to Medial EarlySign CEO Dr. Jeremy Orr, the COVID-19 risk detection system shares elements with the company’s existing flu complications model, whose design was informed by an analysis of tens of millions of people treated by Maccabi and billions of lab results, structured electronic health record data, vital signs, demographics, and other data points. Following a pilot analysis of Maccabi patients’ anonymized records, it identified the top 2% of highest-risk patients (approximately 40,000 people), taking into account variables

Source: venturebeat.com

26/04/2020

Coronavirus et cancer : lancement d’une étude clinique à Lyon pour voir les effets du Covid-19 sur les malades #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance

Mardi 7 avril, des chercheurs Lyonnais ont annoncé le lancement de deux protocoles de recherches, dont une étude clinique incluant des malades du cancer et du coronavirus. Cette dernière permettra de comparer trois traitements pour déterminer le plus efficace contre le Covid-19. .

Source: www.pourquoidocteur.fr

26/04/2020

AnatoScope met au point la personnalisation des masques de protection grâce au scan 3D #esante #hcsmeufr #digitalhealth #Coronavirus #covid-19 #COVID19FR #coronavirusfrance


Spécialiste du double numérique 3D en dentaire et orthopédie, la start-up montpelliéraine AnatoScope s’est lancée dans la mise au point d’une solution de personnalisation des masques de protection fabriqués sur imprimantes 3D, en conjuguant modèles de référence et fichiers de scan 3D de visages. 

Source: www.usine-digitale.fr

Aller au contenu principal